FoxFeed Blog
The latest reporting and analysis on breakthroughs in Parkinson's research and issues that matter most to you.
Poetry Contest Calls for Pieces Related to Health
March 31, 2015
The poetically inclined can share their experiences with Health Affairs for a chance to be published in the journal.
More Medication but Fewer Side Effects
March 29, 2015
Rytary, an extended-release formuation of levodopa/carbidopa, will soon be available for prescription. The treatment requires more pills but comes with less dyskinesia.
Crossfit Community Supports Member with Parkinson's
March 26, 2015
Peter Marconi found both Crossfit and the New England Parkinson's Ride as ways to stay active after being diagnosed with Parkinson's in 2012.
Join the 21st Parkinson's Unity Walk on April 25
March 25, 2015
Ken Aidekman, Co-founder of the Parkinson's Unity Walk reflects on the walk's growth over the last 21 years as we look forward to this year's event which is taking place on Sat., April 25 in NYC.
Q-and-A with 23andMe Parkinson's Community Lead
March 25, 2015
Paul Cannon, PhD, who leads the 23andMe Parkinson's Community, spoke with MJFF about the company's recent news and what it means for Parkinson's disease drug development.
PPMI Now Recruiting Individuals with Genetic Mutation linked to Gaucher Disease
March 24, 2015
The Parkinson's Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J. Fox Foundation (MJFF) is expanding to study individuals with a genetic mutation of the
Alzheimer's Drug Shows Promise in Slowing Disease
March 23, 2015
Pharmaceutical company Biogen last week shared positive results from its study of a drug to slow Alzheimer's progression. These findings have implications for Parkinson's research, as well.
The White House Honors Parkinson's Champions
March 23, 2015
On Monday, March 23, The White House honors MJFF co-founder and executive vice chairman Debi Brooks and Patient Council member Steve DeWitte among nine Champions of Change for Parkinson's patients.
Second Parkinson's Vaccine Reports Positive Safety Results
March 20, 2015
Irish biotechnology company Prothena announced yesterday that its vaccine in development to slow Parkinson's disease (PD) progression was safe and tolerable in a Phase I study.
What Might Early Parkinson's Look Like?
March 18, 2015
This week the New York Times covers "Looking for Parkinson's Sooner." Jane E. Brody writes about symptoms that may appear before the cardinal motor complications of the disease.
Popular Topics
